Clinical Trial Update: Effects of Simvastatin on Uterine Leiomyoma Size [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Johns Hopkins is evaluating whether simvastatin can reduce the size of uterine fibroids; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Johns Hopkins University | Conditions: Fibroid Uterus, Fibroid Tumor | Phase 2 | Status: RECRUITING